Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2008 Aug 15.
Published in final edited form as: J Am Chem Soc. 2007 Feb 17;129(10):2742–2743. doi: 10.1021/ja068280r

Deep Quench: An Expanded Dynamic Range for Protein Kinase Sensors

Vyas Sharma 1, Richard A Agnes 1, David S Lawrence 1,
PMCID: PMC2517079  NIHMSID: NIHMS61941  PMID: 17305340

Abstract

Assays that furnish a fluorescent readout of protein kinase activity provide a means to identify and characterize inhibitory agents, assess structure-function relationships, and correlate enzyme activity with cellular behavior. Although several protein kinase sensors have been described in the literature, their fluorescent response to phosphorylation are generally modest to moderate (1.1 – 8-fold). We have developed a “deep quench” strategy that elicits a dramatic amplification of fluorescence (>60-fold) in cAMP-dependent protein kinase substrates. We describe sensor design, assay development via a combination of library synthesis and screening, characterization of the assay components, and an assessment of two inhibitory species.


Protein kinases catalyze the phosphorylation of serine, threonine, and tyrosine residues in protein and peptide substrates. These enzymes have received considerable attention due to the relationship between aberrant kinase activity and an assortment of human afflictions. Specific and highly sensitive protein kinase sensors furnish a means to rapidly identify inhibitors, assess protein structure/function relationships, and correlate kinase activity with cellular behavior. A large number of kinase assays have been described, however, assays with fluorescent readouts are most easily applied to both in vitro and intracellular settings. GFP-labeled protein and fluorophore-labeled peptide substrates generally deliver, upon phosphorylation, a fluorescent response that varies from 10–60% to 2–9-fold, respectively.1 By comparison, many fluorescent sensors developed for a variety of biomolecules (e.g. proteinases2 and the detection of specific nucleotide sequences3) display enhancements of 25-fold and greater. A large dynamic range offers enhanced sensitivity, thereby furnishing a means to assess target biomolecule behavior under a variety of conditions. Unlike nearly all of the protein kinase assays reported to date,4 the readout described in studies with proteinases2 and molecular beacons3 arise via relief of fluorescent quenching. We report herein an approach, devised around the latter conceptual framework (“Deep Quench”), which delivers a robust protein kinase-elicited fluorescent response.

Our initial studies have focused on the strategy outlined in Scheme 1. A fluorophore-labeled kinase substrate (A) exhibits little or no fluorescence (B) in the presence of a quencher molecule. Upon phosphorylation, the peptide product (C) is sequestered by a phospho-Ser binding domain to form the complex D, which disrupts the interaction between peptide-fluorophore and quencher. The latter should partially or completely restore the fluorescence of the starting peptide.

Scheme 1.

Scheme 1

Enhanced sensing of protein kinase activity via a deeply quenched kinase peptide substrate.

Pyrene was chosen to serve as the fluorophore on an amino acid sequence (AcGRTGRRFSYP-amide) recognized by the cAMP-dependent protein kinase (“PKA”).5 We employed the phospho-Ser binding domain, 14-3-3τ, to serve as the sequestering agent since 14-3-3 domains display a high affinity for phosphoSer-containing peptides (KD < 100 nM).6 The assay was constructed in the following stages:

1. Identification of quenching agents

Fluorescent quenching by a secondary dye is a commonly employed method used to study a wide assortment of biological phenomena.7 However, we required a molecule that would quench fluorophore fluorescence by forming a noncovalent complex with a targeted protein kinase peptide substrate. A library of 47 commercially available dyes (Supporting Information) was assembled and analyzed for the ability to quench the fluorescence of a family of pyrene-substituted peptides P 1P 11 (Table 1). Pyreneacetic acid (Pyr) was attached at different sites along the PKA consensus sequence peptide via a substituted 2,3-diaminopropionic (“Dap”) residue 1 as well as to the N-terminus of the peptide via variable length linkers.

Table 1.

Pyrene-substituted peptides P1P11 containing either Dap (Pyr) at the indicated internal sites (P1P5) or 1-pyreneacetyl appended to the N-terminus of peptides P6P11.

Peptide
P1 Ac-GRTGRRFSDap(Pyr)P-amide graphic file with name nihms61941t1.jpg
P2 Ac-GRTGRRDap(Pyr)SYP-amide
P3 Ac-GRTDap(Pyr)RRFSYP-amide
P4 Ac-GRDap(Pyr)GRRFSYP-amide
P5 Ac-Dap(Pyr)RTGRRFSYP-amide
P6 Pyr-βAla-GRTGRRFSYP-amide
P7 Pyr-Abu-GRTGRRFSYP-amide
P8 Pyr-Ava-GRTGRRFSYP-amide
P9 Pyr-Ahx-GRTGRRFSYP-amide
P10 Pyr-Aoc-GRTGRRFSYP-amide
P11 Pyr-miniPEGTM-GRTGRRFSYP-amide

Ten dyes were identified that serve as effective quenchers (≥40%) of pyrene fluorescence (5 μM peptide and 5 μM dye) for several of the peptides (Supporting Information), including Rose Bengal (2), Aniline Blue WS (3), and Ponceau S (4) (Chart 1). The latter, as well as the other lead quenchers, are negatively charged species. Complex formation of the quencher with the peptide is likely stabilized by electrostatic (positively charged Arg residues) and hydrophobic (fluorophore) interactions.

Chart 1.

Chart 1

Lead quenching dyes of pyrene-peptide fluorescence.

KD values were acquired for the set of the ten lead quenchers with peptide P2, in order to obtain a target range for the quencher:peptide ratios to be employed in the subsequent assays (vide infra). These apparent KD values were determined using the quenching of pyrene fluorescence as a barometer of peptide/quencher complex stability. Since the peptide/quencher pairs may interact via several different modes, not all of which might furnish efficient quenching, the actual KDs could be tighter than suggested by the apparent dissociation constants. KDs with peptide P2 range from 2.8 ± 0.8 μM (Evans Blue) up to 19.6 ± 3.4 μM (Reactive Blue) (Supporting Information). An inner filter effect (at high dye concentrations) was corrected as previously described.8

2. Identification of the lead pyrene-peptide/quencher pair

The eleven pyrene-substituted peptides (P1P11 at 5 μM) were incubated with a 5-, 10-, 25-, and 50-fold molar excess of each of the ten lead quenchers in the presence of PKA, ATP, and the phospho-Ser binding domain 14-3-3τ. Several control experiments were performed, including conducting the assay in the absence of quenching agent. Under the latter conditions, only small enhancements in fluorescence (0 – 64%) were observed (Supporting Information). Since pyrene is an environmentally sensitive fluorophore, these results suggest that the phosphopeptide product binds to 14-3-3 in a manner that inserts pyrene into a modestly hydrophobic environment. At high molar excess dye ratios (>25-fold), pyrene emission is so deeply quenched that background fluorescence significantly contributes to the total fluorescence of the pyrene-peptide sample. Consequently, background subtraction was performed to establish a baseline upon which changes in fluorescence intensity could be quantified (Supporting Information).

Screening, using a multiwell plate reader, revealed several unique quencher/peptide pair combinations that exhibit robust fluorescence changes in response to phosphorylation: Aniline Blue WS 3 and P9 peptide, Ponceau S 4 and P2 peptide, and Rose Bengal 2 and P5 peptide. A more detailed analysis was performed using a standard spectrofluorimeter (Fig. 1). The Rose Bengal/peptide P5 pair exhibits an unprecedented 64-fold phosphorylation-induced enhancement in fluorescence. The Aniline Blue WS/peptide P9 combination is nearly as robust (55-fold), while the Ponceau S/peptide P2 pair is somewhat more subdued (21-fold). The apparent KDs of the two most effective pairs (Rose Bengal/peptide P5: 0.40 ± 0.03 μM; Aniline Blue WS/peptide P9: 0.60 ± 0.03 μM) are significantly tighter than those obtained for the ten lead dyes with peptide P2 (Supporting Information).

Figure 1.

Figure 1

Fluorescence fold-change as a function of time in the presence of Rose Bengal/P5 (25 μM/5 μM), Aniline Blue WS/P9 (50 μM/5 μM), or Ponceau S/P2 (250 μM/5μM) pairs. [PKA] were chosen for each pair so that the reaction would be completed within 30 min [Rose Bengal/P5 (2.5 μM); Aniline Blue WS/P9 (0.7 μM); Ponceau S/P2 (10 nM)].

The peptides P2 (K m = 7.1 ± 1.9 μM; Vmax = 8.4 ± 1.2 μmol/min-mg), P5 (K m = 1.7 ± 0.4 μM; Vmax = 5.7 ± 0.4 μmol/min-mg), and P9 (Km = 1.6 ± 0.9 μM; V max = 7.1 ± 1.2 μmol/min-mg) are all effective PKA substrates in the presence of 14-3-3τ. In addition, we employed the Ponceau S/peptide P 2 combination to examine the inhibitory efficacy of the ATP analogue H99 and a peptide fragment (14–22) of PKI10, a protein-based inhibitor of PKA. Under previously reported conditions ([ATP] = 10 μM), H9 is a reasonably effective inhibitor (IC50 = 1.9 ± 0.2 μM) of PKA.9 However, these conditions are nonphysiological since intracellular levels of ATP are typically above 1 mM. Under the latter conditions ([ATP] = 1 mM), the potency of H9 is dramatically reduced (IC50 = 42 ± 1 μM), as expected for an ATP analogue. In addition, we examined the inhibitory efficacy of the PKI 14–22 peptide inhibitor under identical conditions using two different assays. Both the Deep Quench strategy (1.1 ± 0.1 μM) and the commonly employed radioactive ATP method (1.6 ± 0.2 μM) furnish nearly identical IC50 values.

In summary, we have established a new approach for eliciting robust fluorescent readouts of protein kinase activity. Future studies will include an extension of this methodology to other fluorophores and additional protein kinases. Indeed, a number of basophilic protein kinases phosphorylate sequences that are recognized by 14-3-3 domains. Furthermore, the strategy should be applicable to a wide array of tyrosine kinases with the ready availability of pTyr binding domains.

Supplementary Material

si20070207_105. Supporting Information Available.

Experimental details of peptide synthesis and characterization, screens, and enzyme assays.

Acknowledgments

We gratefully acknowledge the financial support of the National Institutes of Health (GM067198 and NS048406). We thank Dr. Hsien-ming Lee for a gift of PKA and Dr. Melanie Priestman for acquiring the IC50 value of the PKI peptide (radioactive method).

References

  • 1.Rothman DM, Shults MD, Imperiali B. Trends Cell Biol. 2005;15:502–10. doi: 10.1016/j.tcb.2005.07.003. [DOI] [PubMed] [Google Scholar]
  • 2.For example, see Matayoshi ED, Wang GT, Krafft GA, Erickson J. Science. 1990;247:954–8. doi: 10.1126/science.2106161.
  • 3.Tan W, Wang K, Drake TJ. Cur Opin Chem Biol. 2004;8:547–53. doi: 10.1016/j.cbpa.2004.08.010. [DOI] [PubMed] [Google Scholar]
  • 4.A few tyrosine kinase sensors that operate via an unquenching mechanism have been described: Sun H, Low KE, Woo S, Noble RL, Graham RJ, Connaughton SS, Gee MA, Lee LG. Anal Chem. 2005;77:2043–9. doi: 10.1021/ac048280e.Xia W, Rininsland F, Wittenburg SK, Shi X, Achyuthan KE, McBranch DW, Whitten DG. Assay Drug Dev Technol. 2004;2:183–92. doi: 10.1089/154065804323056521.Wang Q, Cahill SM, Blumenstein M, Lawrence DS. J Amer Chem Soc. 2006;128:1808–9. doi: 10.1021/ja0577692.Wang Q, Dai Z, Cahill SM, Blumenstein M, Lawrence DS. J Amer Chem Soc. 2006;128:14016–7. doi: 10.1021/ja065852z.
  • 5.Mitchell RD, Glass DB, Wong CW, Angelos KL, Walsh DA. Biochemistry. 1995;34:528–34. doi: 10.1021/bi00002a018. A FRET-based PKA sensor has been described involving the intramolecular association of a phosphorylated amino acid sequence with 14-3-3 domain: Zhang J, Ma Y, Taylor SS, Tsien RY. Proc Natl Acad Sci USA. 2001;98:14997–5002. doi: 10.1073/pnas.211566798.
  • 6.Yaffe MB, Rittinger K, Volinia S, Caron PR, Aitken A, Leffers H, Gamblin SJ, Smerdon SJ, Cantley LC. Cell. 1997;91:961–71. doi: 10.1016/s0092-8674(00)80487-0. [DOI] [PubMed] [Google Scholar]
  • 7.Johansson MK. Methods Mol Biol. 2006;335:17–29. doi: 10.1385/1-59745-069-3:17. [DOI] [PubMed] [Google Scholar]
  • 8.Levine RL. Clin Chem. 1977;23:2292–301. [PubMed] [Google Scholar]
  • 9.Hidaka H, Inagaki M, Kawamoto S, Sasaki Y. Biochemistry. 1984;23:5036–41. doi: 10.1021/bi00316a032. reported Ki of H9 at 10 μM ATP is 1.9 μM
  • 10.Glass DB, Cheng HC, Mende-Mueller L, Reed J, Walsh DA. J Biol Chem. 1989;264:8802–10. [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

si20070207_105. Supporting Information Available.

Experimental details of peptide synthesis and characterization, screens, and enzyme assays.

RESOURCES